KY SB106 | 2019 | Regular Session
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on February 5 2019 - 25% progression, died in committee
Action: 2019-02-08 - to Health & Welfare (S)
Pending: Senate Health and Welfare Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 5 2019 - 25% progression, died in committee
Action: 2019-02-08 - to Health & Welfare (S)
Pending: Senate Health and Welfare Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Amend KRS 218A.172 to add issues that a practitioner is required to discuss with a patient prior to prescribing or dispensing a controlled substance to a patient; require that the same information is discussed prior to a third sequential prescription; require any discussion records to be kept by the practitioner.
Title
AN ACT relating to discussion with patients on the risks, benefits, and limitations of treatment with controlled substances.
Sponsors
Sen. Alice Kerr [R] |
History
Date | Chamber | Action |
---|---|---|
2019-02-08 | Senate | to Health & Welfare (S) |
2019-02-05 | Senate | introduced in Senate |
Subjects
Kentucky State Sources
Type | Source |
---|---|
Summary | https://apps.legislature.ky.gov/record/19RS/sb106.html |
Text | https://apps.legislature.ky.gov/recorddocuments/bill/19RS/sb106/orig_bill.pdf |